首页 | 本学科首页   官方微博 | 高级检索  
检索        


Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy
Authors:Xi Chen  Aya Haggiagi  Efstathia Tzatha  Lisa M DeAngelis  Bianca Santomasso
Institution:1. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;2. Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
Abstract:ObjectiveTo report the electrodiagnostic features of immune checkpoint inhibitor (ICI)-related neuropathy.MethodsWe retrospectively reviewed clinical presentations and electrodiagnostic features of 23 patients studied after receiving immune checkpoint inhibitors (ICIs). The presentations for electrodiagnostic evaluation included an acute neuropathy or neuromuscular junction disorder. We applied established electrodiagnostic criteria for polyneuropathy and acute demyelinating neuropathy.ResultsWe identified acute demyelinating neuropathy (13 cases), axonal sensory motor neuropathy (5), pure sensory neuropathy (4) and mononeuropathy (1). 13 patients had acute demyelinating neuropathy confirmed by demonstrating demyelination in 2 or more nerves; 3 additional patients had demyelination in only one nerve. Analysis of motor nerve conduction parameters revealed demyelination involving median and ulnar nerve distal motor latencies as well as median, ulnar and peroneal nerve conduction velocities. Conduction block was found in median, ulnar and peroneal nerves. The remaining one-third patients without demyelination had acute painful axonal neuropathy. Coexisting myopathic changes (6) and neuromuscular junction dysfunction (4) were also identified.ConclusionsOur findings suggest that, while immune-mediated motor nerve demyelination is the primary underlying mechanism of ICI-related neuropathy, axonal painful neuropathy can also be an important presentation. Early recognition and effective intervention may reduce morbidity and permanent disability.SignificanceElectrophysiological studies might be useful in the evaluation of ICI-related neuropathy.
Keywords:Corresponding author at: Department of Neurology  Memorial Sloan Kettering Cancer Center  New York  NY 10021  USA    Immune checkpoint inhibitor  Immune-mediated polyneuropathy  Acute demyelinating polyradiculoneuropathy  Electrophysiological study  ICI  immune checkpoint inhibitor  PD1  programmed cell death protein 1  PD-L1  programmed cell death protein 1 ligand  CTLA4  Cytotoxic T-lymphocyte associated protein 4  irAE  immune-related adverse effect  AIDP  acute inflammatory demyelinating polyradiculoneuropathy  GBS  Guillain-Barré syndrome  CIDP  chronic inflammatory demyelinating polyneuropathy  CMAP  compound muscle action potential  SNAP  sensory nerve action potential  CTCAE  common terminology criteria for adverse events
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号